Literature DB >> 30316651

[Tobacco smoking and stopping smoking interventions in patients with TB].

J Perriot1, M Underner2, G Peiffer3.   

Abstract

Tuberculosis and tobacco smoking are two major public health problems causing significant mortality worldwide. Tobacco smoke increases the risk of Mycobacterium tuberculosis infection, severe pulmonary or extrapulmonary TB, and death of TB. In emerging countries, quitting smoking is one way to control the TB epidemic. Compared with non-smokers, smokers with tuberculosis are less observant of anti-tuberculosis treatment. Smoking abstinence improves the course of their illness, the treatment compliance and facilitates the final cure justifying smoking cessation interventions. The involvement of all healthcare professionals in helping smokers stopping smoking is required.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Observance thérapeutique; Sevrage tabagique; Smoking; Smoking cessation; Tabagisme; Therapeutic compliance; Therapeutic education of patients; Tuberculose; Tuberculosis; Éducation thérapeutique des patients

Mesh:

Year:  2018        PMID: 30316651     DOI: 10.1016/j.pneumo.2018.09.002

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  3 in total

1.  Risk Factors of Relapse After Smoking Cessation: Results in China Family Panel Studies From 2010 to 2018.

Authors:  Naifan Hu; Zhenfan Yu; Yurun Du; Jiangping Li
Journal:  Front Public Health       Date:  2022-07-01

2.  Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis.

Authors:  Abay Burusie; Fikre Enquesilassie; Adamu Addissie; Berhe Dessalegn; Tafesse Lamaro
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

3.  Risk factor for 31-day unplanned readmission to hospital in patients with pulmonary tuberculosis in China.

Authors:  Jing Cao; Shengpeng Liu; Juhua Huang
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.